Showing Events in 1
Track from 07:30am to
08:15am
Morning Remarks
Grand Ballroom
Showing Events in 1
Track from 08:15am to
08:40am
Opening Keynote
Grand Ballroom
Showing Events in 1
Track from 08:40am to
09:20am
Morning Session
Grand Ballroom
Showing Events in 1
Track from 09:20am to
10:00am
Grand Opening of the IO360° Networking Café
Showing Events in 1
Track from 10:00am to
11:15am
New Technologies in Transformational Biology Plenary
Grand Ballroom
Track Chair:
Axel Hoos, MD, PhD,
Former CEO, Scorpion Therapeutics
Showing Events in 2
Tracks from 11:15am to
12:30pm
Track 1: IO Novel Technologies Showcase A
Grand Ballroom
Track Chair:
David Leung, MD, PhD,
Head of Imaging, Daiichi Sankyo
Track 2: IO Novel Technologies Showcase B
Back Bay Ballroom AB
Track Chair:
Dinesh de Alwis, PhD,
SVP, Clinical Drug Development, Generate Biomedicines
Showing Events in 2
Tracks from 12:30pm to
01:45pm
Lunch & One-on-One Meetings Begin
Women Leaders in IO Luncheon & Panel Discussion - Pre-Registration with Ticket Required
Constitution Ballroom AB
Showing Events in 2
Tracks from 01:45pm to
03:20pm
Track 1: New Tech in Transformational Biology (continued)
Grand Ballroom
Track Chair:
James Gulley, MD, PhD, FACP,
Co-Director, Center for Immuno-Oncology, CCR & Clinical Director, National Cancer Institute, NIH
Track 2: Oncology Clinical Operations
Back Bay Ballroom AB
Track Chair:
Andy Lee,
SVP, Head of Global Clinical Trial Operations, Merck & Co., Inc.
Carol Haddad,
Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1
Track from 03:20pm to
04:00pm
Afternoon Networking Break
Showing Events in 2
Tracks from 04:00pm to
06:10pm
Track 1: Breakthroughs in Translational Science, Imaging and Biomarkers (Pt 1)
Grand Ballroom
Track Chair:
Marisa Dolled-Filhart, PhD,
Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Track 2: Oncology Clinical Operations (continued)
Back Bay Ballroom AB
Track Chair:
Carol Haddad,
Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1
Track from 06:00pm to
07:00pm
11th Annual Networking Reception & One-on-One Meetings
Showing Events in 1
Track from
07:30am to 08:15am
Morning Remarks
Grand Ballroom
Showing Events in 1
Track from
08:15am to 08:40am
Opening Keynote
Grand Ballroom
Showing Events in 1
Track from
08:40am to 09:20am
Morning Session
Grand Ballroom
Showing Events in 1
Track from
09:20am to 10:00am
Grand Opening of the IO360° Networking Café
Showing Events in 1
Track from
10:00am to 11:15am
New Technologies in Transformational Biology Plenary
Grand Ballroom
Track Chair:
Axel Hoos, MD, PhD,
Former CEO, Scorpion Therapeutics
Showing Events in 2
Tracks from
11:15am to 12:30pm
Track 1: IO Novel Technologies Showcase A
Grand Ballroom
Track Chair:
David Leung, MD, PhD,
Head of Imaging, Daiichi Sankyo
Track 2: IO Novel Technologies Showcase B
Back Bay Ballroom AB
Track Chair:
Dinesh de Alwis, PhD,
SVP, Clinical Drug Development, Generate Biomedicines
Showing Events in 2
Tracks from
12:30pm to 01:45pm
Lunch & One-on-One Meetings Begin
Women Leaders in IO Luncheon & Panel Discussion - Pre-Registration with Ticket Required
Constitution Ballroom AB
Showing Events in 2
Tracks from
01:45pm to 03:20pm
Track 1: New Tech in Transformational Biology (continued)
Grand Ballroom
Track Chair:
James Gulley, MD, PhD, FACP,
Co-Director, Center for Immuno-Oncology, CCR & Clinical Director, National Cancer Institute, NIH
Track 2: Oncology Clinical Operations
Back Bay Ballroom AB
Track Chair:
Andy Lee,
SVP, Head of Global Clinical Trial Operations, Merck & Co., Inc.
Carol Haddad,
Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1
Track from
03:20pm to 04:00pm
Afternoon Networking Break
Showing Events in 2
Tracks from
04:00pm to 06:10pm
Track 1: Breakthroughs in Translational Science, Imaging and Biomarkers (Pt 1)
Grand Ballroom
Track Chair:
Marisa Dolled-Filhart, PhD,
Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Track 2: Oncology Clinical Operations (continued)
Back Bay Ballroom AB
Track Chair:
Carol Haddad,
Executive Director, Oncology Clinical Sciences and Study Management, Merck Research Laboratories
Showing Events in 1
Track from
06:00pm to 07:00pm
11th Annual Networking Reception & One-on-One Meetings